BioLineRx Ltd. (TLV: BLRX)
Israel
· Delayed Price · Currency is ILS · Price in ILA
12.40
0.00 (0.00%)
Nov 17, 2024, 3:49 PM IDT
BioLineRx Revenue
BioLineRx had revenue of $5.39M USD in the quarter ending June 30, 2024. This brings the company's revenue in the last twelve months to $17.05M. In the year 2023, BioLineRx had annual revenue of $4.80M.
Revenue (ttm)
$17.05M
Revenue Growth
n/a
P/S Ratio
2.11
Revenue / Employee
$215.80K
Employees
79
Market Cap
151.18M ILS
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBioLineRx News
- 4 weeks ago - BioLineRx receives USPTO allowance of new composition of matter patent on motixafortide - Seeking Alpha
- 4 weeks ago - BioLineRx Announces USPTO Allowance of New Composition of Matter Patent on Motixafortide - PRNewsWire
- 2 months ago - BioLineRx Launches 'Mobilization Matters': A Digital Resource for People with Multiple Myeloma Preparing for Stem Cell Collection - PRNewsWire
- 3 months ago - BioLineRx Ltd. (BLRX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - BioLineRx GAAP EPS of $0.00, revenue of $5.39M - Seeking Alpha
- 3 months ago - BioLineRx Reports Second Quarter 2024 Financial Results and Recent Corporate and Portfolio Updates - PRNewsWire
- 3 months ago - biolinerx Q2 Earnings Preview - Seeking Alpha
- 3 months ago - BioLineRx to Report Second Quarter 2024 Results on August 15, 2024 - PRNewsWire